Alliancebernstein L.P. Purchases 812,337 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Alliancebernstein L.P. increased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 273.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,109,045 shares of the biotechnology company’s stock after buying an additional 812,337 shares during the period. Alliancebernstein L.P.’s holdings in Axon Enterprise were worth $659,128,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Prestige Wealth Management Group LLC increased its stake in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at approximately $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise in the 4th quarter worth approximately $45,000. Stonebridge Financial Group LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth approximately $53,000. Finally, GPS Wealth Strategies Group LLC boosted its position in shares of Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after acquiring an additional 40 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Down 2.9 %

Shares of NASDAQ:AXON opened at $534.95 on Monday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $40.99 billion, a P/E ratio of 138.23, a P/E/G ratio of 5.17 and a beta of 1.12. The company’s 50-day moving average price is $589.62 and its two-hundred day moving average price is $550.61. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Insider Transactions at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on AXON. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.